AU2001256435A1 - Use of lactobacillus casei in immunostimulatory compositions - Google Patents
Use of lactobacillus casei in immunostimulatory compositionsInfo
- Publication number
- AU2001256435A1 AU2001256435A1 AU2001256435A AU2001256435A AU2001256435A1 AU 2001256435 A1 AU2001256435 A1 AU 2001256435A1 AU 2001256435 A AU2001256435 A AU 2001256435A AU 2001256435 A AU2001256435 A AU 2001256435A AU 2001256435 A1 AU2001256435 A1 AU 2001256435A1
- Authority
- AU
- Australia
- Prior art keywords
- lactobacillus casei
- immunostimulatory compositions
- immunostimulatory
- compositions
- casei
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229940017800 Lactobacillus casei Drugs 0.000 title 1
- 240000004403 Lactobacillus casei Species 0.000 title 1
- 235000013958 Lactobacillus casei Nutrition 0.000 title 1
- 230000003308 immunostimulating Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR00/06679 | 2000-05-25 | ||
FR0006679A FR2809312B1 (en) | 2000-05-25 | 2000-05-25 | USE OF L. CASEI IN IMMUNOSTIMULATING COMPOSITIONS |
PCT/FR2001/001310 WO2001089541A1 (en) | 2000-05-25 | 2001-04-27 | Use of lactobacillus casei in immunostimulatory peptides |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2001256435A1 true AU2001256435A1 (en) | 2002-02-21 |
AU2001256435B2 AU2001256435B2 (en) | 2006-06-29 |
Family
ID=8850597
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU5643501A Pending AU5643501A (en) | 2000-05-25 | 2001-04-27 | Use of lactobacillus casei in immunostimulatory peptides |
AU2001256435A Ceased AU2001256435B2 (en) | 2000-05-25 | 2001-04-27 | Use of lactobacillus casei in immunostimulatory compositions |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU5643501A Pending AU5643501A (en) | 2000-05-25 | 2001-04-27 | Use of lactobacillus casei in immunostimulatory peptides |
Country Status (28)
Country | Link |
---|---|
US (1) | US7604809B2 (en) |
EP (1) | EP1283714B1 (en) |
JP (1) | JP2003534284A (en) |
CN (1) | CN1194707C (en) |
AR (1) | AR028626A1 (en) |
AT (1) | ATE332143T1 (en) |
AU (2) | AU5643501A (en) |
BG (1) | BG65884B1 (en) |
BR (1) | BR0111135A (en) |
CA (1) | CA2410350C (en) |
CZ (1) | CZ303600B6 (en) |
DE (1) | DE60121327T2 (en) |
DK (1) | DK1283714T3 (en) |
EA (1) | EA005081B1 (en) |
ES (1) | ES2267763T3 (en) |
FR (1) | FR2809312B1 (en) |
HK (1) | HK1055898A1 (en) |
HR (1) | HRP20020935A2 (en) |
HU (1) | HUP0302041A3 (en) |
IL (1) | IL152980A0 (en) |
MA (1) | MA25760A1 (en) |
MX (1) | MXPA02011636A (en) |
NO (1) | NO332369B1 (en) |
PL (1) | PL201801B1 (en) |
PT (1) | PT1283714E (en) |
SK (1) | SK18272002A3 (en) |
WO (1) | WO2001089541A1 (en) |
ZA (1) | ZA200209087B (en) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6800744B1 (en) * | 1997-07-02 | 2004-10-05 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
GB0009294D0 (en) | 2000-04-15 | 2000-05-31 | Sec Dep For The Home Departmen | Improvements in and relating to analysis of DNA samples |
US9610347B2 (en) * | 2001-04-30 | 2017-04-04 | Cortcontrol | Vaccination response for immunodeficiency or high cortisol |
CN1317385C (en) * | 2003-05-30 | 2007-05-23 | 上海光明乳业股份有限公司 | Cheese lactobacillus Bd-II strain and use for decreasing blood fat |
US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
ATE361101T1 (en) * | 2004-08-24 | 2007-05-15 | Nutricia Nv | FOOD COMPOSITION CONTAINING INDIGESTIBLE OLIGOSACCHARIDES |
ZA200705844B (en) * | 2004-12-15 | 2008-09-25 | Van Der Westhuzen Corne Floris | Detoxifying and immunity-booster composition |
EP1683425A1 (en) * | 2005-01-21 | 2006-07-26 | Compagnie Gervais Danone | Use of a fermented milk containing L. Casei for the manufacture of a composition for the prevention or treatment of a delayed-type hypersensitivity reaction |
ES2264368B1 (en) * | 2005-02-11 | 2007-12-01 | Francisco Exposito Mesa | FOOD OR DIETETIC COMPLEMENT COMPOSED BY PRODUCTS FROM THE LIST OF MICROORGANISMS. |
BRPI0611492B1 (en) | 2005-05-31 | 2021-10-13 | Mars, Incorporated | BIFIDOBACTERIA PROBIOTICS FELINE |
WO2006130187A1 (en) | 2005-05-31 | 2006-12-07 | The Iams Company | Feline probiotic lactobacilli |
CA2662226C (en) | 2006-09-10 | 2020-08-04 | Glycotope Gmbh | Fully human high yield production system for improved antibodies and proteins |
FR2912657B1 (en) * | 2007-02-16 | 2009-04-17 | Gervais Danone Sa | USE OF LACTOBACILLUS CASEI TO ENHANCE PROTECTION INDUCED BY ANTI-INFLUENZA VACCINATION. |
WO2009021585A1 (en) * | 2007-08-13 | 2009-02-19 | Dsm Ip Assets B.V. | Probiotic bacteria for rducing the occurence of symptoms of winter infections |
WO2009067000A1 (en) * | 2007-11-20 | 2009-05-28 | N.V. Nutricia | Composition with synbiotics |
EP2119365B1 (en) | 2008-05-13 | 2017-08-16 | Glycotope GmbH | Fermentation process |
CA2722738C (en) * | 2008-05-13 | 2017-04-25 | Glycotope Gmbh | Fermentation process |
US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
EP2153837A1 (en) | 2008-08-14 | 2010-02-17 | Compagnie Gervais Danone | Compositions comprising Lactobacillus casei for improving resistance to common infectious diseases |
FR2937252B1 (en) * | 2008-10-17 | 2011-05-20 | Pf Medicament | ASSOCIATION OF AN EXTRACT OF SUREAU AND A L. PARACASEI STRAIN |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
BR112012016894A2 (en) * | 2010-01-08 | 2015-09-15 | Gervais Danone Sa | lactobacilli with antioxidant action. |
EA031179B1 (en) * | 2010-03-12 | 2018-11-30 | Компани Жервэ Данон | Lactic acid bacteria for coeliac disease |
CN105288616B (en) * | 2010-10-15 | 2018-10-19 | 科.汉森有限公司 | immunologic adjuvant |
EP2455092A1 (en) | 2010-11-11 | 2012-05-23 | Nestec S.A. | Non-replicating probiotic micro-organisms protect against upper respiratory tract infections |
US9700610B2 (en) | 2011-08-22 | 2017-07-11 | Glycotope Gmbh | Microorganisms carrying a tumor antigen |
WO2014038929A1 (en) | 2012-09-07 | 2014-03-13 | N.V. Nutricia | Probiotics for producing antiviral factors |
CA3100608A1 (en) | 2018-05-18 | 2019-11-21 | Daiichi Sankyo Co., Ltd. | Anti-muc1 antibody-drug conjugate |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05236872A (en) * | 1992-02-27 | 1993-09-17 | Takanashi Nyugyo Kk | Food containing lactic acid bacterium |
JP4112021B2 (en) * | 1994-02-16 | 2008-07-02 | 明治乳業株式会社 | Immunostimulant using lactic acid bacteria |
WO1996020607A1 (en) * | 1995-01-02 | 1996-07-11 | Compagnie Gervais Danone | Milk starter culture and use thereof for preparing antidiarrhoeal products |
CN1150314C (en) * | 1997-08-21 | 2004-05-19 | 纽西兰乳品局 | Immunity enhancing lactic acid bacteria |
US6699517B2 (en) * | 1997-11-28 | 2004-03-02 | Compagnie Gervais Danone | Method for preparing food products by fermenting soy milk with streptococcus thermophilus |
IT1298918B1 (en) * | 1998-02-20 | 2000-02-07 | Mendes Srl | USE OF ARGININE DEIMINASE BACTERIA TO INDUCE APOPTOSIS AND / OR REDUCE AN INFLAMMATORY REACTION AND PHARMACEUTICAL COMPOSITIONS |
KR100324441B1 (en) * | 1999-02-08 | 2002-02-27 | 이은선 | Food for preventing gastritis, gastric and duodenal ulcers |
-
2000
- 2000-05-25 FR FR0006679A patent/FR2809312B1/en not_active Expired - Fee Related
-
2001
- 2001-04-27 HU HU0302041A patent/HUP0302041A3/en unknown
- 2001-04-27 SK SK1827-2002A patent/SK18272002A3/en not_active Application Discontinuation
- 2001-04-27 AU AU5643501A patent/AU5643501A/en active Pending
- 2001-04-27 MX MXPA02011636A patent/MXPA02011636A/en active IP Right Grant
- 2001-04-27 JP JP2001585785A patent/JP2003534284A/en active Pending
- 2001-04-27 BR BR0111135-3A patent/BR0111135A/en not_active IP Right Cessation
- 2001-04-27 PT PT01929743T patent/PT1283714E/en unknown
- 2001-04-27 EP EP01929743A patent/EP1283714B1/en not_active Expired - Lifetime
- 2001-04-27 AT AT01929743T patent/ATE332143T1/en active
- 2001-04-27 DK DK01929743T patent/DK1283714T3/en active
- 2001-04-27 CA CA2410350A patent/CA2410350C/en not_active Expired - Lifetime
- 2001-04-27 CN CNB018100511A patent/CN1194707C/en not_active Expired - Fee Related
- 2001-04-27 US US10/276,315 patent/US7604809B2/en not_active Expired - Fee Related
- 2001-04-27 WO PCT/FR2001/001310 patent/WO2001089541A1/en active IP Right Grant
- 2001-04-27 AU AU2001256435A patent/AU2001256435B2/en not_active Ceased
- 2001-04-27 ES ES01929743T patent/ES2267763T3/en not_active Expired - Lifetime
- 2001-04-27 IL IL15298001A patent/IL152980A0/en unknown
- 2001-04-27 CZ CZ20024189A patent/CZ303600B6/en unknown
- 2001-04-27 PL PL358408A patent/PL201801B1/en unknown
- 2001-04-27 EA EA200201248A patent/EA005081B1/en not_active IP Right Cessation
- 2001-04-27 DE DE60121327T patent/DE60121327T2/en not_active Expired - Lifetime
- 2001-05-24 AR ARP010102498A patent/AR028626A1/en unknown
-
2002
- 2002-11-08 ZA ZA200209087A patent/ZA200209087B/en unknown
- 2002-11-20 BG BG107299A patent/BG65884B1/en unknown
- 2002-11-21 NO NO20025595A patent/NO332369B1/en not_active IP Right Cessation
- 2002-11-25 HR HR20020935A patent/HRP20020935A2/en not_active Application Discontinuation
- 2002-12-20 MA MA26968A patent/MA25760A1/en unknown
-
2003
- 2003-11-12 HK HK03108188A patent/HK1055898A1/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001256435A1 (en) | Use of lactobacillus casei in immunostimulatory compositions | |
AU5643501A (en) | Use of lactobacillus casei in immunostimulatory peptides | |
AU2001294814A1 (en) | Pumpcn compositions and uses thereof | |
AU5002301A (en) | Cosmetic compositions comprising exfoliating enzymes and uses thereof | |
AU2001241474A1 (en) | Biosensor compositions and methods of use | |
AU2001250875A1 (en) | Anti-microbial and immunostimulating composition | |
AU2001234437A1 (en) | Deicing compositions and methods of use | |
AU2001229593A1 (en) | Mineral water composition containing bifidobacterium probiotic agent | |
AU2001272011A1 (en) | Siderophores-producing bifidobacteria thereby and uses thereof | |
WO2002036145A3 (en) | Kahalalide f formulation | |
AU2001276461A1 (en) | Cleaning compositions and their use | |
AU7364700A (en) | Use of psychrotrophic bacterium in biotechnology applications | |
AU2001261317A1 (en) | Immunostimulant compositions and associated methods | |
HUP0303936A3 (en) | Novel composition and use | |
AU2001297556A1 (en) | 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof | |
PL362753A1 (en) | New strain of lactobacillus paracasei | |
AU2001238091A1 (en) | Tgf-beta therapeutics, compositions and methods of use | |
AUPQ760400A0 (en) | Herbical formulations and methods of use thereof | |
AU2001239954A1 (en) | Cleaning compositions and use thereof | |
AU3002901A (en) | Bacterial galactanases and use thereof | |
AU2001242019A1 (en) | Compositions and methods for use thereof in modifying the genomes of microorganisms | |
AU2001236001A1 (en) | Immune enhancement compositions and use thereof | |
AU4304700A (en) | Immunostimulatory pharmaceutical composition and its use protocol | |
AU2001231141A1 (en) | Novel human septin and uses thereof | |
AU2001297794A1 (en) | Methods and compositions of human proteins and uses thereof. |